An Atypical Age-Specific Pattern of Hepatocellular Carcinoma in Peru: A Threat for Andean Populations

@article{Bertani2013AnAA,
  title={An Atypical Age-Specific Pattern of Hepatocellular Carcinoma in Peru: A Threat for Andean Populations},
  author={St{\'e}phane Bertani and Pascal Pineau and Sebastian Loli and Julien Moura and Mirko Zimic and Eric Deharo and Eloy Ruiz},
  journal={PLoS ONE},
  year={2013},
  volume={8}
}
Background In South America, the highest incidence of primary liver cancer is observed in Peru. However, national estimations on hepatocellular carcinoma incidence and mortality are approximated using aggregated data from surrounding countries. Thus, there is a lack of tangible information from Peru that impairs an accurate description of the local incidence, presentation, and outcomes of hepatocellular carcinoma. The present study attempts to fill this gap and assesses the clinical… Expand
A Peculiar Mutation Spectrum Emerging from Young Peruvian Patients with Hepatocellular Carcinoma
TLDR
The results confirm the specificity of Peruvian hepatocellular carcinoma at the molecular genetic level and support the theory of a consistent collapse in the Hippo axis, as well as an expression of the stemness factor NANOG in high alpha-fetoprotein-expressing hepato cellular carcinomas. Expand
On hepatocellular carcinoma in South America and early-age onset of the disease.
TLDR
The current knowledge on HCC presentation in Peru is reviewed, highlighting the well-documented occurrence of an early-age nosological form of the disease in Andean descent populations and the implications for liver cancer screening, management, and prevention. Expand
Hepatocellular carcinoma surgery outcomes in the developing world: A 20-year retrospective cohort study at the National Cancer Institute of Peru
TLDR
It appears that staging systems and associated therapeutic algorithms designed for use in the developed world remain inadequate in certain populations, especially in the context of Peruvian patients, and clinicians in the developing world should reconsider management guidelines pertaining to hepatocellular carcinoma. Expand
Liver clear cell foci and viral infection are associated with non-cirrhotic, non-fibrolamellar hepatocellular carcinoma in young patients from South America
TLDR
The findings confirm the occurrence of a particular setting of HCC in South America, a region where the pathophysiology of liver cancer remains largely unexplored. Expand
A Seven-Year Retrospective Study on the Surveillance of Hepatitis B in Laos
TLDR
Public health decisions should be taken urgently to rationalise vaccination and provide fair access to early diagnosis and treatment; otherwise the burden of HBV-associated diseases will be overwhelming for Laos in the near future. Expand
Epidemiology of Liver Cancer in Latin America: Current and Future Trends.
TLDR
A high prevalence of fatty liver disease in the region is a matter of concern, reflecting the current scenario in many Western countries, and interventions to increase screening coverage, expand healthcare access, and implement continuing medical training are key challenges to be overcome. Expand
Early-onset liver cancer in South America associates with low hepatitis B virus DNA burden
TLDR
It is concluded that in Peru, and maybe in other populations with Americas’ indigenous ancestry, HBV-associated liver tumorigenesis might differ significantly from that generally observed in the rest of the world. Expand
Herbal Medicine Practices of Patients With Liver Cancer in Peru: A Comprehensive Study Toward Integrative Cancer Management
TLDR
It is confirmed that HM remains one of the principal primary health care resources in Peru, even for a severe disease like liver cancer, and traditional, complementary and alternative medicine practices should be taken into consideration in Peruvian health programs aiming to educate the population in cancer prevention and treatment, as well as integrative cancer management. Expand
Negative serology of Fasciola hepatica infection in patients with liver cancer in Peru: a preliminary report.
TLDR
The pre-existence of F. hepatica infection in HCC patients needs to be further investigated in epidemiological and experimental studies. Expand
Association of Fasciola hepatica Infection with Liver Fibrosis, Cirrhosis, and Cancer: A Systematic Review
TLDR
Future high-quality studies are needed to determine the role of F. hepatica on the development of liver fibrosis, liver cirrhosis, and cancer in humans. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 59 REFERENCES
Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei.
TLDR
Estimations of the incidence of hepatocellular carcinoma in Mozambique have been calculated and together with rates observed in South Africa among mineworkers from the same Province indicate very high levels of incidence, suggesting the existence of a subgroup of highly susceptible individuals. Expand
Hepatocellular carcinoma: a global view
TLDR
Environments with disparate resource levels require different strategies for the optimal management of HCC, and programs to provide targeted therapy at low cost, similar to the approach used for HIV therapy in the developing world, should be pursued. Expand
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.
TLDR
Application of existing public health methods for infection prevention, such as vaccination, safer injection practice, or antimicrobial treatments, could have a substantial effect on the future burden of cancer worldwide. Expand
The resurrection of alphafetoprotein.
TLDR
The data presented support the use of AFP response seen after locoregional therapy as an ancillary method of assessing tumour response and survival, as well as an early objective screening tool for progression by imaging. Expand
Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma
TLDR
Significant clinical-pathologic differences exist among HCC patients with underlying HBV vs. HCV and these differences impact eligibility for potentially-curative therapy and prognosis. Expand
Staging systems for hepatocellular carcinoma: should we all use the BCLC system?
TLDR
The presence of underlying liver cirrhosis in patients with HCC adds an important dimension that cannot be ignored when discussing prognosis and treatment for these patients, and it is what differentiates HCC from other solid tumors. Expand
Non-Viral Causes of Hepatocellular Carcinoma
TLDR
This report describes the mechanisms responsible for the disease progression and HCC in case of metabolic liver disease and identifies the frequency of HCC development in the disorders described. Expand
Global burden of hepatitis C: considerations for healthcare providers in the United States.
TLDR
Awareness of the global epidemiology of HCV infection is important for US healthcare providers treating foreign-born patients from countries where HCv infection is endemic and for counseling patients who travel to these countries. Expand
A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
TLDR
New scoring criteria that included tumor size, tumor number, and pretransplant AFP level as prognostic factors could expand usefully current selection criteria for transplantation without detrimentally affecting outcome in the living donor transplantation setting for HCC. Expand
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
TLDR
The results for 20 world regions are presented, summarizing the global patterns for the eight most common cancers, and striking differences in the patterns of cancer from region to region are observed. Expand
...
1
2
3
4
5
...